Since the beginning of 2018, shares of Bombardier have seen a 60 per cent increase in value, as investors gain confidence in the company’s latest version of a turnaround. It wasn’t long ago that the Montreal-based aerospace and transportation company was taking government hand-outs to keep itself afloat, while at the same time being mired in a number of public relations disasters, including bribery charges and exorbitant pay increases for its executives.
The company is still mired in debt but its balance sheet has been looking better, while quarterly earnings have consistently beaten consensus expectations. And more recently, Bombardier’s partnership with Airbus on the C-Series jet program (now known as the Airbus A220), which was originally greeted with skepticism, is starting to look like a real win for BBD.
Only a couple of weeks into the handover, Airbus has already announced two major deals for 60 planes each — one with US carrier JetBlue and another with a yet-to-be-named US-based carrier. Stuchberry says that Bombardier’s own poor sales of the C-Series were due to concerns over production, which were erased once Airbus took the reins.
“The situation we have now is that with Airbus coming in, all of a sudden we have credibility on the sale side,” said Stuchberry, in conversation with BNN Bloomberg this week. “I think with the Bombardier C-Series, you’ve seen some great orders come in and now you’ve got the clout. There’s no doubt now for anyone buying a C-Series, or the A-220 Series, as it’s called now, that they’re going to deliver this thing because Airbus is there. That takes away that question mark of, do I order all these planes and then I don’t get them delivered or they go bankrupt or all the rest.”
As for Bombardier’s share price, which has now dropped 13 per cent from a high of $5.58 on July 11, Stuchberry says to keep waiting for a larger pullback.
“I wouldn’t be super-aggressive in buying it because it’s hard to know what the valuation is, and I think the market has already said, ‘Hey, I think this is great. Let’s move the price up,’” he says. “So, I would be a buyer on weakness on this. If it pulls back to $4.00, $4.25, something like that.”
ATB Capital Markets analyst Tim Monachello raised his rating on Questor Technology (Questor Technology Stock Quote, Chart, News, Analysts, Financials… [Read More]
Ventum Capital Markets analyst Amr Ezzat maintained a “Buy” rating and C$47.00 target price for Tecsys (Tecsys Stock Quote, Chart,… [Read More]
Roth Capital Markets analyst Scott Searle maintained a “Buy” rating and US$17.50 target price for Gogo (Gogo Stock Quote, Chart,… [Read More]
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$12.00 target price on Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock… [Read More]
Paradigm Capital analyst Marvin Wolff maintained a “Buy” rating and $0.55 target price for CHAR Technologies (CHAR Technologies Stock Quote,… [Read More]
Beacon Securities analyst Donangelo Volpe maintained a “Buy” rating and $2.00 target price for Imaflex (Imaflex Stock Quote, Chart, News,… [Read More]